BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29221201)

  • 1. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
    Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
    Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
    Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
    Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
    Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
    Chou CH; Chou YE; Chuang CY; Yang SF; Lin CW
    PLoS One; 2017; 12(2):e0171583. PubMed ID: 28152093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
    Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
    Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
    PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
    Shiu BH; Hsieh MH; Ting WC; Chou MC; Chang LC; Huang CC; Su SC; Yang SF
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34071523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the rs1966265 and rs351855
    Carrillo-Dávila IA; Garibaldi-Ríos AF; Figuera LE; Gómez-Meda BC; Zúñiga-González GM; Puebla-Pérez AM; García-Verdín PM; Castro-García PB; Gutiérrez-Hurtado IA; Torres-Mendoza BM; Gallegos-Arreola MP
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.
    Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X
    DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma.
    Ding YF; Wen YC; Chuang CY; Lin CW; Yang YC; Liu YF; Chang WM; Chang LC; Yang SF; Chien MH
    Front Oncol; 2021; 11():684941. PubMed ID: 34268119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
    Li JP; Huang HC; Yang PJ; Chang CY; Chao YH; Tsao TC; Huang H; Hung YC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32781755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
    Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
    Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.
    Chen L; Lei Z; Ma X; Huang Q; Zhang X; Zhang Y; Hao P; Yang M; Zhao X; Chen J; Liu G; Zheng T
    Sci Rep; 2016 Sep; 6():33604. PubMed ID: 27640814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
    Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.
    Zhu Q; Liu T
    Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
    Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
    Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPACT OF FGFR4 (GLY388ARG) GENE POLYMORPHISM ALONG WITH VISFATIN CYTOKINE AND HIGH MOBILITY GROUP BOX-1 (HMGB1) ON ACUTE CHOLECYSTITIS.
    Alfuaadi IH; Altamemi IA
    Wiad Lek; 2022; 75(5 pt 2):1242-1247. PubMed ID: 35758438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.
    Weng CJ; Chen MK; Lin CW; Chung TT; Yang SF
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S319-27. PubMed ID: 21512861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.